Lir Life Sciences (STU:N790) FFO

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:N790 Lir Life Sciences Corp STU:N790
20 GF Score
Price €0.10
View Full Analysis

What is Lir Life Sciences FFO?

FFO (Funds from operations) only applies to REITs.

STU:N790
20GF Score
Lir Life Sciences Corp STU:N790
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Lir Life Sciences Business Description

Address 505-1505 West 2nd Avenue, Vancouver, BC, CAN, V6J 1H2
Lir Life Sciences Corp is a biotechnology company developing transdermal and sublingual drug-delivery technologies for GLP-1-based obesity therapies, with the focus of improving accessibility and patient experience.
20GF Score

Get the complete analysis for STU:N790

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.10
Price